PRO-Br treatment decreased the number of hyperphosphorylated tau-positive cells in the P301S mouse model, and also exhibited exceptional efficacy in reversing motor and memory impairments in 3xTg-AD and P301S mouse models. The gene discussed is MAPT; the disease is Alzheimer disease.